[
  "Yu De-Chao, also known as Michael Yu, is the chairman and CEO of Innovent Biologics, a China-headquartered biotech company.",
  "Innovent went public at the Hong Kong Stock Exchange in 2018. ",
  "Yu holds a PhD in molecular genetics from the Chinese Academy of Sciences.",
  "Yu had a postdoc position in pharmaceutical chemistry at the University of California San Francisco in 1993-1996.",
  "Yu had a postdoc position in pharmaceutical chemistry at the University of California, San Francisco in 1993-1996."
]